Parkinson's Disease Therapeutics Market Moving Beyond Symptomatic Relief: The Rise of Disease-Modifying Agents
What is the core shift in the Parkinson’s therapeutic landscape?
The historical cornerstone of the Parkinson’s Disease Therapeutics Market has been symptomatic relief, primarily through levodopa-based therapies. However, we are now entering an era where the focus is shifting toward disease-modifying therapies...
0 Compartilhamentos
258 Visualizações